News & Updates

Show Multimedia Only

Menopausal hormone therapy prevents relapse in women with SSD

07 Nov 2024

Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.

Menopausal hormone therapy prevents relapse in women with SSD

07 Nov 2024

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

07 Nov 2024

Children with homozygous familial hypercholesterolaemia (HoFH) achieve significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) with the microsomal triglyceride transfer protein (MTP) inhibitor lomitapide, which represents an efficient LDL receptor-independent treatment option, according to the open-label phase III APH-19 trial.

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

07 Nov 2024

Original New Drug Application Approvals by US FDA (16-31 October 2024)

07 Nov 2024

New drug applications approved by US FDA as of 16-31 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2024)

07 Nov 2024

Vitamin K2 supplementation eases leg cramps in seniors

06 Nov 2024 by

Daily supplementation with vitamin K2 helps minimize the frequency, intensity, and duration of nocturnal leg cramps in older adults while having a good safety profile, as shown in a study.

Vitamin K2 supplementation eases leg cramps in seniors

06 Nov 2024

Is rapid-rate oxaliplatin safer than standard infusion?

06 Nov 2024

Rapid infusion of oxaliplatin appears to have minimal treatment modifications relative to standard administration but may lead to a higher incidence of peripheral neuropathy (PN), according to a study.

Is rapid-rate oxaliplatin safer than standard infusion?

06 Nov 2024

Beyond medication dispensing: The expanding role of pharmacists in healthcare

06 Nov 2024

In celebration of World Pharmacists Day on September 25, Kenvue brought together a panel of experts to discuss how pharmacists are contributing in significant ways to delivering effective, accessible healthcare and improving patient outcomes. Mr Paul Sinclair, President of the International Pharmaceutical Federation, identified the roles pharmacists play in primary healthcare. Dr Angeline Yong, Consultant Dermatologist and Dermatological Laser Surgeon, Angeline Yong Dermatology Clinic, Singapore, described pharmacists as trusted advisors guiding good skincare practices. Dr Giridhar Sethuraman, Chief Consultant Neonatologist at Neolife Children’s Hospital, Chennai, India, focused on the role of pharmacists in managing atopic dermatitis in children. Dr Edwin Heng, Periodontist at Farrer Park Medical Centre, Singapore, discussed the critical connection between oral health and overall well-being. Professor Mohammad Haniki from the Kulliyyah of Pharmacy, International Islamic University of Malaysia, emphasized the importance of training pharmacists to support smoking cessation efforts.

Beyond medication dispensing: The expanding role of pharmacists in healthcare

06 Nov 2024

Increased risk of inflammatory CNS diseases following anti-TNF therapy for autoimmune diseases

06 Nov 2024 by

Compared with conventional therapies, exposure to tumour necrosis factor (TNF) inhibitors is associated with increased risk of inflammatory central nervous system (CNS) diseases, irrespective of background autoimmune disease or TNF inhibitor type, a recent meta-analysis has found.

Increased risk of inflammatory CNS diseases following anti-TNF therapy for autoimmune diseases

06 Nov 2024

Pegaspargase biosimilar safe to use in childhood ALL

05 Nov 2024

The biosimilar Pegaspargase, when combined with chemotherapy, demonstrates a favourable safety profile in children with acute lymphoid leukemia (ALL) treated according to ICiCLe ALL-14 protocol, a study has shown.

Pegaspargase biosimilar safe to use in childhood ALL

05 Nov 2024

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

05 Nov 2024 by

The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

05 Nov 2024

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

05 Nov 2024

In the treatment of diabetic macular edema (DME) in the subgroup of patients with baseline best-corrected visual acuity (BCVA) of 20/50 or worse, the bispecific antibody faricimab has been shown to improve visual acuity as much as the anti-VEGF aflibercept, with the added advantage of a greater decrease in retinal thickness and reduced injection frequency.

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

05 Nov 2024

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Menopausal hormone therapy prevents relapse in women with SSD

Menopausal hormone therapy prevents relapse in women with SSD

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

Original New Drug Application Approvals by US FDA (16-31 October 2024)

Original New Drug Application Approvals by US FDA (16-31 October 2024)

Vitamin K2 supplementation eases leg cramps in seniors

Vitamin K2 supplementation eases leg cramps in seniors

Is rapid-rate oxaliplatin safer than standard infusion?

Is rapid-rate oxaliplatin safer than standard infusion?

Beyond medication dispensing: The expanding role of pharmacists in healthcare

Beyond medication dispensing: The expanding role of pharmacists in healthcare

Increased risk of inflammatory CNS diseases following anti-TNF therapy for autoimmune diseases

Increased risk of inflammatory CNS diseases following anti-TNF therapy for autoimmune diseases

Pegaspargase biosimilar safe to use in childhood ALL

Pegaspargase biosimilar safe to use in childhood ALL

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs